Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Circulation
|
July 21, 2016
Response by Hubers and Brown to Letter Regarding Article, "Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition"
Scott A Hubers, Nancy J Brown
Circulation
|
March 16, 2016
Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition
Scott A Hubers, Nancy J Brown
Mayo Clinic Proceedings
|
April 18, 2020
Infective Endocarditis: A Contemporary Review
Scott A Hubers, Daniel C DeSimone, Bernard J Gersh, et al.
Circulation. Heart Failure
|
November 8, 2024
Renal Effects of Combination Phosphodiesterase V Inhibition and Low-Dose B-Type Natriuretic Peptide in Acute Heart Failure: A Randomized Clinical Trial
Scott A Hubers, Sherry L Benike, Bradley K Johnson, et al.
Heart (British Cardiac Society)
|
August 5, 2020
B-type natriuretic peptide and cardiac remodelling after myocardial infarction: a randomised trial
Scott A Hubers, John A Schirger, S Jeson Sangaralingham, et al.
The Journal of Allergy and Clinical Immunology
|
July 24, 2018
Endogenous bradykinin and B1-B5 during angiotensin-converting enzyme inhibitor-associated angioedema
Scott A Hubers, Kevin Kohm, Shouzuo Wei, et al.
Journal of the American Heart Association
|
January 10, 2022
Cardiorenal Effects of Long-Term Phosphodiesterase V Inhibition in Pre-Heart Failure
Scott A Hubers, Siu-Hin Wan, Fadi W Adel, et al.
Analytical Chemistry
|
December 3, 2019
Quantification of Neuropeptide Y and Four of Its Metabolites in Human Plasma by Micro-UHPLC-MS/MS
Céline Vocat, Marielle Dunand, Scott A Hubers, et al.
Journal of the Endocrine Society
|
September 19, 2019
Dipeptidyl Peptidase 4 Inhibition Increases Postprandial Norepinephrine via Substance P (NK1 Receptor) During RAAS Inhibition
Jessica R Wilson, Scott Jafarian Kerman, Scott A Hubers, et al.
Hypertension (Dallas, Tex. : 1979)
|
January 20, 2022
DPP4 (Dipeptidyl Peptidase-4) Inhibition Increases Catecholamines Without Increasing Blood Pressure During Sustained ACE (Angiotensin-Converting Enzyme) Inhibitor Treatment
Jessica R Wilson, Erica M Garner, Mona Mashayekhi, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Circulation
|
July 21, 2016
Response by Hubers and Brown to Letter Regarding Article, "Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition"
Scott A Hubers, Nancy J Brown
Circulation
|
March 16, 2016
Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition
Scott A Hubers, Nancy J Brown
Mayo Clinic Proceedings
|
April 18, 2020
Infective Endocarditis: A Contemporary Review
Scott A Hubers, Daniel C DeSimone, Bernard J Gersh, et al.
Circulation. Heart Failure
|
November 8, 2024
Renal Effects of Combination Phosphodiesterase V Inhibition and Low-Dose B-Type Natriuretic Peptide in Acute Heart Failure: A Randomized Clinical Trial
Scott A Hubers, Sherry L Benike, Bradley K Johnson, et al.
Heart (British Cardiac Society)
|
August 5, 2020
B-type natriuretic peptide and cardiac remodelling after myocardial infarction: a randomised trial
Scott A Hubers, John A Schirger, S Jeson Sangaralingham, et al.
The Journal of Allergy and Clinical Immunology
|
July 24, 2018
Endogenous bradykinin and B1-B5 during angiotensin-converting enzyme inhibitor-associated angioedema
Scott A Hubers, Kevin Kohm, Shouzuo Wei, et al.
Journal of the American Heart Association
|
January 10, 2022
Cardiorenal Effects of Long-Term Phosphodiesterase V Inhibition in Pre-Heart Failure
Scott A Hubers, Siu-Hin Wan, Fadi W Adel, et al.
Analytical Chemistry
|
December 3, 2019
Quantification of Neuropeptide Y and Four of Its Metabolites in Human Plasma by Micro-UHPLC-MS/MS
Céline Vocat, Marielle Dunand, Scott A Hubers, et al.
Journal of the Endocrine Society
|
September 19, 2019
Dipeptidyl Peptidase 4 Inhibition Increases Postprandial Norepinephrine via Substance P (NK1 Receptor) During RAAS Inhibition
Jessica R Wilson, Scott Jafarian Kerman, Scott A Hubers, et al.
Hypertension (Dallas, Tex. : 1979)
|
January 20, 2022
DPP4 (Dipeptidyl Peptidase-4) Inhibition Increases Catecholamines Without Increasing Blood Pressure During Sustained ACE (Angiotensin-Converting Enzyme) Inhibitor Treatment
Jessica R Wilson, Erica M Garner, Mona Mashayekhi, et al.
Page
of 2